Cargando…
Rivaroxaban attenuates neutrophil maturation in the bone marrow niche
Pharmacological inhibition of factor Xa by rivaroxaban has been shown to mediate cardioprotection and is frequently used in patients with, e.g., atrial fibrillation. Rivaroxaban's anti-inflammatory actions are well known, but the underlying mechanisms are still incompletely understood. To date,...
Autores principales: | Schneckmann, R., Döring, M., Gerfer, S., Gorressen, S., Heitmeier, S., Helten, C., Polzin, A., Jung, C., Kelm, M., Fender, A. C., Flögel, U., Grandoch, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425524/ https://www.ncbi.nlm.nih.gov/pubmed/37580509 http://dx.doi.org/10.1007/s00395-023-01001-5 |
Ejemplares similares
-
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
por: Kohlmorgen, Christina, et al.
Publicado: (2021) -
Multiparametric MRI identifies subtle adaptations for demarcation of disease transition in murine aortic valve stenosis
por: Quast, Christine, et al.
Publicado: (2022) -
Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction
por: Merx, Marc W., et al.
Publicado: (2013) -
The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence
por: Schiffer, Sonja, et al.
Publicado: (2023) -
Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms
por: Dumontet, Erwan, et al.
Publicado: (2021)